[1] Sidhu P, O’Kane HO. Self-managed anticoagulation: results from a two-year prospective randomized trial with heart valve patients[J]. Ann Thorac Surg, 2001, 72 (5): 1523-1527.
[2] Kontozis L, Skudicky D, Hopley MJ, et al. Long-term follow-up of St.Jude medical prosthesis in a young rheumatic population using low-level warfarin anticoagulation: an analysis of the temporal distribution of causes of death [J]. Am J Cardiol, 1998, 81(6): 736-739.
[3] 董 力,石应康,邓承祺,等. 应用国际标准比值监测心脏机械瓣膜替换术后抗凝治疗[J]. 中华胸心血管外科杂志,1999,15 (3): 167-169.
[4] Zhou XM, zhuang W, Hu JG, et al. Low-dose anticoagulation in Chinese patients with mechanical heart valves[J]. Asian Cardiovasc Thorac Ann, 2005, 13(4): 341-344.
[5] Torn M, Cannegiter SC, Bollen WL, et al. Optimal level of oral anticoagulant therapy for the prevention of arterial thrombosis in patients with mechanical heart valve prostheses, atrial fibrillation, or myocardial infarction: a prospective study of 4202 patients[J]. Arch Intern Med, 2009,169 (13): 1203-1209.
[6] 刘 岩,孟 旭,陈宝田,等. 人工机械瓣膜低强度抗凝治疗的标准[J]. 中华胸心血管外科杂志,2001,17 (5): 263-265.
[7] Acar J, Lung B, Boissel JP, et al. AREVA: multicenter randomized comparison of low-dose versus standard-dose anticoagulation in patients with mechanical prosthetic heart valves[J]. Circulation, 1996,94 (9): 2107-2112.
[8] Hirsh J. Oral anticoagulation drugs [J]. N Engl J Med, 1991, 324(26): 1865-1875.
[9] 董 力,石应康,赵雍凡,等. 心脏机械瓣替换术后126例抗凝治疗随访[J]. 中华胸心血管外科杂志,1996,12 (3): 149-151.